RecruitingPhase 3NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Sponsor: Merck Sharp & Dohme LLC
Corvallis, OR · +53 more sites
Parkinson's Disease clinical trials in Corvallis, OR
2 recruiting parkinson's disease studies with a site in Corvallis, OR.
All trials in Corvallis, OR · All Parkinson's Disease trials
RecruitingPhase 3NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Sponsor: Merck Sharp & Dohme LLC
Corvallis, OR · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.